journal article·2019-03Open access

A physics-based model explains the prion-like features of neurodegeneration in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Johannes Weickenmeier, Mathias Jucker, Alain Goriely, Ellen Kuhl

Abstract

Prion disease is characterized by a chain reaction in which infectious misfolded proteins force native proteins into a similar pathogenic structure. Recent studies have reinforced the hypothesis that the prion paradigm–the templated growth and spreading of misfolded proteins–could help explain the progression of a variety of neurodegenerative disorders. However, our current understanding of prion-like growth and spreading is rather empirical. Here we show that a physics-based reaction-diffusion model can explain the growth and spreading of misfolded protein in Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. To characterize the progression of misfolded proteins across the brain, we combine the classical Fisher–Kolmogorov equation for population dynamics with an anisotropic diffusion model and simulate misfolding across a sagittal section and across the entire brain. In a systematic sensitivity analysis, we probe the role of the individual model parameters and show that the misfolded protein concentration is sensitive to the coefficients of growth, extracellular diffusion, and axonal transport, to the axonal fiber orientation, and to the initial seeding region. Our model correctly predicts amyloid- β deposits and tau inclusions in Alzheimer’s disease, α -synuclein inclusions in Parkinson’s disease, and TDP-43 inclusions in amyotrophic lateral sclerosis and displays excellent agreement with the histological patterns in diseased human brains. When integrated across the brain, our concentration profiles result in biomarker curves that display a striking similarity with the sigmoid shape and qualitative timeline of clinical biomarker models. Our results suggest that misfolded proteins in various neurodegenerative disorders grow and spread according to a universal law that follows the basic physical principles of nonlinear reaction and anisotropic diffusion. Our findings substantiate the notion of a common underlying principle for the pathogenesis of a wide variety of neurodegenerative disorders, the prion paradigm. A more quantitative understanding of the growth and spreading of misfolded amyloid- β , tau, α -synuclein, and TDP-43 would allow us to establish a prognostic timeframe of disease progression. This could have important clinical implications, ranging from more accurate estimates of the socioeconomic burden of neurodegeneration to a more informed design of clinical trials and pharmacological intervention.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Prion Diseases and Protein Misfolding · Alzheimer's disease research and treatments · Neurological diseases and metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Prions: Health scare and biological challenge10.1038/35052063 ↗
2. Molecular mechanisms of chronic traumatic encephalopathy10.1016/j.cobme.2017.02.003 ↗
3. Neuropathological staging of Alzheimer-related changes10.1007/BF00308809 ↗
4. Staging of brain pathology related to sporadic Parkinson’s disease10.1016/S0197-4580(02)00065-9 ↗
5. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis10.1002/ana.23937 ↗
6. The dynamics of Alzheimer’s disease biomarkers in the Alzheimer’s disease neuroimaging initiative cohort10.1016/j.neurobiolaging.2010.04.024 ↗
7. Structural cues to prion replication10.1126/science.7909169 ↗
8. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein10.1073/pnas.0903691106 ↗
9. Prionics or the kinetic basis of prion diseases10.1016/S0301-4622(96)02250-8 ↗
10. The wave of advance of advantageous genes10.1111/j.1469-1809.1937.tb02153.x ↗
11. The clinical use of structural MRI in Alzheimer disease10.1038/nrneurol.2009.215 ↗
12. Propagation of tau misfolding from the outside to the inside of a cell10.1074/jbc.M808759200 ↗
13. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration10.1093/brain/aww230 ↗
14. Mechanics of the brain: perspectives, challenges, and opportunities10.1007/s10237-015-0662-4 ↗
15. Roles of tau protein in health and disease10.1007/s00401-017-1707-9 ↗
16. Is tau ready for admission to the prion club?10.4161/pri.19912 ↗
17. The spread of neurodegenerative disease10.1056/NEJMcibr1202401 ↗
18. The shrinking brain: Cerebral atrophy following traumatic brain injury
19. Prion-like properties of tau protein: the importance of extracellular tau as therapeutic target10.1074/jbc.R114.549295 ↗
20. Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders10.1371/journal.pcbi.1003956 ↗
21. Biomarker modeling of Alzheimer’s disease10.1016/j.neuron.2013.12.003 ↗
22. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade10.1016/S1474-4422(09)70299-6 ↗
23. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie?10.1016/0092-8674(93)90635-4 ↗
24. Pathological protein seeding in Alzheimer disease and other neurodegenerative disorders10.1002/ana.22615 ↗
25. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases10.1038/nature12481 ↗
26. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases10.1038/s41593-018-0238-6 ↗
27. Investigation of the equation of diffusion combined with increasing of the substance and its application to a biology problem
28. Quantifying the kinetic parameters of prion replication10.1016/S0301-4622(99)00016-2 ↗
29. Murray · 2002
30. Mathematical modelling of glioma growth: The use of diffusion tensor imaging (DTI) data to predict the anisotropic pathways of cancer invasion10.1016/j.jtbi.2013.01.014 ↗
31. Kinetics of prion growth10.1016/S0006-3495(03)74767-5 ↗
32. Prions. nobel lecture10.1073/pnas.95.23.13363 ↗
33. Prions, prionoids and protein misfolding disorders10.1038/s41576-018-0011-4 ↗
34. Neurodegenerative diseases target large-scale human brain networks10.1016/j.neuron.2009.03.024 ↗
35. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics10.1038/nrd2176 ↗
36. The prion model for progression and diversity of neurodegenerative diseases10.1016/S1474-4422(17)30037-6 ↗
37. A patient-specific anisotropic diffusion model for brain tumor spread10.1007/s11538-017-0271-8 ↗
38. Phases of a beta-deposition in the human brain and its relevance for the development of AD10.1212/WNL.58.12.1791 ↗
39. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study10.1016/S1474-4422(13)70044-9 ↗
40. Neurodegenerative diseases: expanding the prion concept10.1146/annurev-neuro-071714-033828 ↗
41. Corruption and spread of pathogenic proteins in neurodegenerative disease10.1074/jbc.R112.399378 ↗
42. The multiphysics of prion-like diseases: progression and atrophy10.1103/PhysRevLett.121.158101 ↗
43. World Alzheimer Report, 2016. Improving healthcare for people living with dementia. Coverage, quality and costs now and in the future. Alzheimer’s Disease International, London, 2016.